These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 10573186

  • 21. The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice.
    Tsuji M, Takeda H, Matsumiya T, Nagase H, Narita M, Suzuki T.
    Life Sci; 2001 Mar 02; 68(15):1717-25. PubMed ID: 11270618
    [Abstract] [Full Text] [Related]

  • 22. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
    Wu HE, Sun HS, Terashivili M, Schwasinger E, Sora I, Hall FS, Uhl GR, Tseng LF.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):103-7. PubMed ID: 16445907
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term voluntary access to running wheels decreases kappa-opioid antinociception.
    D'Anci KE, Gerstein AV, Kanarek RB.
    Pharmacol Biochem Behav; 2000 Jun 15; 66(2):343-6. PubMed ID: 10880688
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M, Khotib J, Suzuki M, Ozaki S, Yajima Y, Suzuki T.
    J Neurochem; 2003 Jun 15; 85(5):1171-9. PubMed ID: 12753076
    [Abstract] [Full Text] [Related]

  • 31. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
    Chen X, Geller EB, Adler MW.
    Eur J Pharmacol; 2007 Feb 14; 557(1):32-6. PubMed ID: 17173891
    [Abstract] [Full Text] [Related]

  • 32. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ, Członkowski A, Lipkowski A, Herz A.
    J Pharmacol Exp Ther; 1989 Oct 14; 251(1):342-50. PubMed ID: 2571723
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK, Meert TF.
    J Pharmacol Exp Ther; 2002 Sep 14; 302(3):1253-64. PubMed ID: 12183687
    [Abstract] [Full Text] [Related]

  • 35. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB, Welch SP.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):119-27. PubMed ID: 10607867
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, Negus SS.
    J Pharmacol Exp Ther; 2003 Dec 03; 307(3):1054-64. PubMed ID: 14557380
    [Abstract] [Full Text] [Related]

  • 40. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates.
    Ko MC, Husbands SM.
    J Pharmacol Exp Ther; 2009 Jan 03; 328(1):193-200. PubMed ID: 18842704
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.